2016
[PP.13.07] HYPERTENSION AND CARDIOVASCULAR DISEASE RISK REDUCTION IN OBESE PATIENTS WITH BINGE EATING DISORDER
Grilo C. [PP.13.07] HYPERTENSION AND CARDIOVASCULAR DISEASE RISK REDUCTION IN OBESE PATIENTS WITH BINGE EATING DISORDER. Journal Of Hypertension 2016, 34: e192-e193. DOI: 10.1097/01.hjh.0000491879.94394.fc.Peer-Reviewed Original ResearchBinge-eating disorderAnti-obesity medicationsCVD risk factorsObese patientsBlood pressureMetabolic syndromeCardiovascular disease risk reductionStepped-care treatmentSubgroup of patientsDisease risk reductionMental Health SurveyObese BED patientsBinge Eating DisorderCognitive behavioral therapyOverall significant decreaseMedical comorbiditiesRemission rateRisk factorsInitial respondersHealth SurveyHeart rateBED patientsHypertensionMixed model analysisPatients
2015
Pharmacological treatment of binge eating disorder: update review and synthesis
Reas DL, Grilo CM. Pharmacological treatment of binge eating disorder: update review and synthesis. Expert Opinion On Pharmacotherapy 2015, 16: 1463-1478. PMID: 26044518, PMCID: PMC4491373, DOI: 10.1517/14656566.2015.1053465.Peer-Reviewed Original ResearchConceptsCertain medicationsWeight lossDifferent medication classesOverview of pharmacotherapyMedical comorbiditiesMedication classesMinimal weight lossFirst medicationPharmacological treatmentRecurrent bingeLong-term effectsMedicationsSuperior outcomesMental disordersPharmacotherapyEvidence baseDisorder diagnosisStatistical ManualBingePhase IIIDisordersInclusion requirementsTrialsCombination approachRCTs